Metabolomics-Proteomics Combined Approach Identifies Differential Metabolism-Associated Molecular Events between

Mengqiu Wu1, Hui Ye1, Chang Shao1

  • 1Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines and ‡School of Pharmacy, China Pharmaceutical University , Tongjiaxiang #24, Nanjing 210009, China.

Insights

Cancer cell metabolism significantly impacts chemotherapy outcomes, influencing apoptosis and senescence. This study reveals distinct metabolic shifts in senescent cells promoting survival via DNA repair and ROS elimination, unlike apoptotic cells.

Area of Science:

  • Cancer Biology
  • Metabolic Pathways
  • Cellular Senescence and Apoptosis

Background:

  • Cellular fate decisions (apoptosis and senescence) are critical responses to chemotherapy.
  • Cancer cell metabolism plays a crucial role in mediating these cell fate decisions.
  • Targeting metabolic pathways offers a novel therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To comprehensively describe metabolic pathways involved in chemotherapy-induced cell senescence and apoptosis.
  • To identify metabolism-associated molecular events mediating cellular responses to senescence and apoptosis.
  • To explore biochemical mechanism-based differences between apoptosis and senescence using a combined biomics approach.

Main Methods:

  • Employed a combined metabolomics-proteomics approach.
  • Utilized doxorubicin-treated human breast cancer cells (MCF7) as a model system.
  • Analyzed metabolic pathway activity in senescent versus apoptotic cellular models.

Main Results:

  • Senescent cells showed significant upregulation of the tricarboxylic acid cycle, pentose phosphate pathway, and nucleotide synthesis, with reduced fatty acid synthesis.
  • Apoptotic cells exhibited overall reduced metabolic pathway activity, with the exception of the arginine and proline pathway.
  • Senescent cells displayed metabolic adaptations for survival, including reactive oxygen species (ROS) elimination and DNA damage repair.

Conclusions:

  • Metabolomics and proteomics are valuable tools for elucidating biochemical differences between apoptosis and senescence.
  • Distinct metabolic reprogramming underlies senescent versus apoptotic cell fates in response to chemotherapy.
  • Senescent cells activate specific metabolic pathways to survive chemotherapy by managing DNA damage and oxidative stress.

Related Concept Videos